SXI Life Sciences
7.288,53
PKT
+69,99
PKT
+0,97
%
Werbung
Analysen zu SXI Life Sciences-Werten
Datum | Rating | Analyst | |
---|---|---|---|
14.09.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
11.09.18 | Novartis buy | Citigroup Corp. | |
11.09.18 | Novartis Neutral | UBS AG | |
11.09.18 | Roche Underperform | BNP PARIBAS | |
11.09.18 | Novartis Neutral | BNP PARIBAS | |
10.09.18 | Roche Neutral | Merrill Lynch & Co., Inc. | |
10.09.18 | Novartis buy | Merrill Lynch & Co., Inc. | |
07.09.18 | Novartis buy | Jefferies & Company Inc. | |
07.09.18 | Roche buy | Jefferies & Company Inc. | |
07.09.18 | Roche overweight | JP Morgan Chase & Co. | |
06.09.18 | Novartis buy | Kepler Cheuvreux | |
06.09.18 | Novartis Neutral | JP Morgan Chase & Co. | |
08.08.18 | Roche Hold | Kepler Cheuvreux | |
02.08.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
30.07.18 | Roche overweight | Barclays Capital | |
27.07.18 | Roche buy | S&P Capital IQ | |
27.07.18 | Roche Reduce | HSBC | |
27.07.18 | Roche Underperform | Credit Suisse Group | |
27.07.18 | Roche Hold | Deutsche Bank AG | |
27.07.18 | Roche buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
27.07.18 | Roche overweight | Barclays Capital | |
26.07.18 | Roche kaufen | DZ BANK | |
26.07.18 | Roche Hold | Kepler Cheuvreux | |
26.07.18 | Roche Neutral | UBS AG | |
26.07.18 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
26.07.18 | Roche overweight | JP Morgan Chase & Co. | |
24.07.18 | Roche Hold | Kepler Cheuvreux | |
24.07.18 | Novartis Neutral | JP Morgan Chase & Co. | |
20.07.18 | Roche overweight | JP Morgan Chase & Co. | |
20.07.18 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
20.07.18 | Novartis Neutral | UBS AG | |
19.07.18 | Roche buy | Baader Bank | |
19.07.18 | Novartis Neutral | Credit Suisse Group | |
19.07.18 | Roche overweight | JP Morgan Chase & Co. | |
19.07.18 | Novartis kaufen | DZ BANK | |
19.07.18 | Novartis Neutral | JP Morgan Chase & Co. | |
19.07.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
19.07.18 | Novartis Equal weight | Barclays Capital | |
19.07.18 | Novartis Neutral | UBS AG | |
19.07.18 | Novartis Hold | Deutsche Bank AG |